A detailed history of Ironwood Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ironwood Financial, LLC holds 13,973 shares of BMY stock, worth $559,758. This represents 0.17% of its overall portfolio holdings.

Number of Shares
13,973
Previous 13,973 -0.0%
Holding current value
$559,758
Previous $716,000 5.73%
% of portfolio
0.17%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

BUY
$57.89 - $64.73 $8,683 - $9,709
150 Added 1.09%
13,973 $810,000
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $101,594 - $119,005
1,717 Added 14.18%
13,823 $818,000
Q4 2020

Jan 26, 2021

BUY
$57.74 - $65.43 $691,840 - $783,982
11,982 Added 9662.9%
12,106 $751,000
Q1 2020

Apr 27, 2020

BUY
$46.4 - $67.43 $1,856 - $2,697
40 Added 47.62%
124 $7,000
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $4,133 - $5,391
84 New
84 $5,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ironwood Financial, LLC Portfolio

Follow Ironwood Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Financial, LLC with notifications on news.